Recent Company News

• 09:53 AM ET Dec 24, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (94 total)

• 10:02 AM ET Dec 23, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (170 total)

• 07:32 AM ET Dec 22, 2025
  

  Brainsway announces Optum Behavioral Health expands medical policy applicable to Deep TMS ($17.11, 0.00)

• 10:02 AM ET Dec 10, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (126 total)

• 07:33 AM ET Nov 17, 2025
  

  Brainsway launches trial of Deep TMS 360 System for Alcohol Use Disorder ($15.76, 0.00)

• 09:16 AM ET Nov 13, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:17 AM ET Nov 13, 2025
  

  StreetAccount Summary - US Pre-market trading

• 06:04 AM ET Nov 13, 2025
  

  BrainsWay receives FDA clearance of Deep TMS as adjunct therapy for major depressive disorder (MDD) in adolescents aged 15 to 21 ($15.78, 0.00)

• 11:33 AM ET Nov 11, 2025
  

  Transcript Intelligence: Brainsway Q3 Earnings Guidance ($14.97, -1.16)

• 11:33 AM ET Nov 11, 2025
  

  Transcript Intelligence: Brainsway Q3 Earnings Themes ($14.97, -1.16)